Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-02-19EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Hulio, a biosimilar of adalimumab, for multiple inflammatory indications including hidradenitis suppurativa, psoriasis, u…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Nutrition and Clinical Outcomes in IBD
This clinical trials update reports that the study 'Nutrition and Clinical Outcomes in IBD' is currently recruiting. It investigates nutriti…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients [Phase 1]
A Phase 1 clinical trial update evaluating the safety and efficacy of CNK-UT009 in difficult-to-treat inflammatory bowel disease, including …
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing Colonoscopy
A completed clinical trial evaluated tissue cytomegalovirus viral load and associated factors in pediatric patients undergoing colonoscopy, …
-
EMA approval · 2026-02-17EMA Authorised: Inflectra (infliximab) — Pfizer Europe MA EEIG
EMA authorised Inflectra (infliximab) as a biosimilar to Remicade for multiple inflammatory diseases including rheumatoid and psoriatic arth…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis
A clinical trial is evaluating the change in disease activity with risankizumab in adults with moderate to severe ulcerative colitis; recrui…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis [Phase 1]
A Phase 1b trial evaluating the safety of MB310 in patients with active, mild-to-moderate ulcerative colitis has completed.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis [Phase 3]
Phase 3 clinical trial update evaluating fecal microbiota transplantation to prevent recurrent pouchitis in ulcerative colitis patients with…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease
This clinical trial update describes evaluating a switch from intravenous to subcutaneous vedolizumab for inflammatory bowel disease, includ…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC)
A multi-centre prospective cohort study on acute severe ulcerative colitis (Elevate ASUC) is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis [Phase 3]
A Phase 3 clinical trial evaluating frozen encapsulated multidonor stool filtrate for active ulcerative colitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases
A clinical trial is recruiting to assess whether a structured therapeutic education session increases participation in adapted physical acti…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Pilot Study on the Efficacy and Safety of a Novel Synbiotic Formula (SGR11) in Patients With Inflammatory Bowel Disease (IBD) [NA]
This clinical trial update describes a pilot study to assess the efficacy and safety of SGR11, a novel synbiotic formula, in patients with i…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
A clinical trial (SHIFT-IBD) is evaluating switching to the IL-23 inhibitor guselkumab in active inflammatory bowel disease patients who pre…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) [NA]
The PRInCE-UC clinical trial evaluating prebiotics to reduce inflammation and improve clinical endpoints in ulcerative colitis has completed…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]
A Phase 2 clinical trial evaluating tilpisertib fosmecarbil in adults with moderately to severely active ulcerative colitis is currently rec…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
A clinical trial is evaluating the ALPCO Calprotectin CLIA assay to determine expected calprotectin values in healthy subjects; the study is…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease [NA]
A clinical trial evaluating Efferon LPS for Crohn's disease and ulcerative colitis is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis [NA]
A clinical trial is evaluating fecal noninvasive biomarkers oriented control versus usual care for ulcerative colitis, and it is currently n…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool
A clinical trial evaluating the ALPCO Calprotectin CLIA assay for measuring calprotectin levels in human stool in inflammatory bowel disease…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 trial assessing the safety and efficacy of OD-07656 with subsequent vedolizumab therapy for moderately to severely active ulcerative…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis [Phase 3]
A Phase 3 clinical trial update announcing ongoing recruitment for a study of risankizumab in young participants with ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice [Phase 4]
An open-label Phase 4 study of Ozanimod in moderate-to-severe ulcerative colitis was terminated, with results posted in February 2026.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population [Phase 1]
Phase 1 trial of fecal microbiota transplantation in an expanded ulcerative colitis population; study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative Colitis [Phase 4]
This Phase 4 trial update investigates whether interleukin-7 receptor gene polymorphism is associated with ulcerative colitis risk. The stud…